“…While quality control methods were previously suggested, they only focussed on the genome (potentially missing alternatively spliced variants that would have been detected by studying the transcriptome) [80,81], or on the proteome (potentially missing mRNAs whose translation is downregulated by microRNAs [83,84] or covered aspects of the data such as GC content [40], noise [12,13] source material quality [62,63,67,70,86], different experimental methods [64][65][66][71][72][73][74][76][77][78][79] or read quality [87][88][89][90][91][92][93][94][95], with few investigations focusing on the tissuespecificity issues [75,96], even when two or more methods were used in the same study [97][98][99][100][101]. A common shortcoming of many previous attempts is that tissue specificity of the genes was reported [102][103][104][105][106][1...…”